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Association (CHIRA) data is explored. The advantages and limitations of the CHIRA 
data are described. Results: Although there have been abstract disclosures in 
scientific conferences, a search in PubMed (January 8, 2014) found no manuscripts 
published that presented analyses using CHIRA data. It uses ICD-10 codes and col-
lects cross-sectional data annually from inpatient claims records from sample cit-
ies. Advantages include the availability of demographics, institution, diagnoses, 
medications, service use, hospital stay, insurance type and service cost information 
for a large, diverse local population.  Limitations include the lack of longitudinal 
patient records, incomplete data, the lack of outpatient data and standardized bill-
ing codes, and limited access for research purposes. ConClusions: At present 
claims data in China are relatively difficult to access and to use. However the use 
of claims data for health services research is expected to increase in line with 
planned enhancements to data availability and quality, and the increasing needs 
for RWE by decision makers.
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objeCtives: To develop a functional and validated database for quality assur-
ance and improving patient outcomes and establishing institutional integ-
rity. Methods: The Cardiothoracic surgery division at the Aga Khan University 
Hospital maintains a computerized database of all the patients undergoing cardiac 
surgery since July 2006. For this study, data of 1236 patients operated between July 
2006 and Dec 2013 was analyzed. Major measures of outcomes included in-hospital 
and 30 day mortality and morbidity outcomes like reopening, sepsis prolong venti-
lation, arrhythmias low cardiac output syndrome. Results: Out of a total of 1236 
heart surgeries, the most common open heart surgeries were VSD 27%, TOF 24% 
were, and 13% were ASD. In closed heart 51% were Modified BT shunts, 17% were 
PDA. The overall 30-day mortality in open heart was 7.0%, and in closed heart it 
was 7.3%. Post-surgery more common  complication  in open heart surgery was 
prolong ventilation which was 39%,arrhythmias 14%,reopenings 11% and sepsis 
5%total morbidity was 29% while in closed heart most common complication 
was prolong ventilation which was 31%, total morbidity was 21%. Readmissions 
after 30 day of Discharge were 8.4% mainly for respiratory infection. Followed 
with 14% lost to follow-ups 85% patients were alive, 0.6% were died at 30 day 
patients follow up. ChAnges depend on dAtAbAse: VSD: on table extubation 
or extubation with 4 hours – minimal morbidity and early discharges. ASD: on 
table extubation. ConClusions: Updated and stringently maintained database 
helped to identify deficiencies, strength and trends of the Pediatric and Congenital 
Cardiac surgery program at our hospital and also to design strategies for continu-
ing improvement in patient care. Also provides scientific evidence for comparing 
results with other institutions of the region and world.
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objeCtives: Injuries in sports, including professional American football, are a 
major public health problem affecting millions of young and adult athletes around 
the world each year. While most injuries are minor, some end seasons, careers, and 
may even result in long-term disability. No outcomes databases exist that focus 
on injuries in the National Football League (NFL). We sought to develop a database 
that’s longitudinal and includes key injury impact outcomes. Methods: Four years 
of data including information on any player that played 1+ regular season games 
between 2010 and 2013 were adapted from NFL.com, ESPN.com, TSN.com and sev-
eral other reputable online sources. Five different and unique data types, all capable 
of being merged with one another and used in longitudinal analyses, were stored 
as SAS datasets: Player Background (e.g., age, weight, position), Games Played, NFL 
Injury Report, Injured Reserve List, and Schedule and Conditions (e.g., field sur-
face, weather conditions, referee).  Data from the NFL Injury Report and Injured 
Reserve List contain every significant injury to NFL players during the 4-year period 
including concussions, knees, ankles, hamstrings, etc. Injury Impacts include games 
missed due to injuries as well as season- and career-ending injuries. Results: 
Data on 3,193 unique NFL players are included in the database. About 7,700 player-
seasons are captured that cover nearly 91,000 player-games. About 18,500 Injury 
Reports are recorded on these players resulting in more than 6,000 missed games. 
In addition, almost all 959 Injured Reserve List injuries are season-ending and sig-
nificantly raise the risk of ending a player’s career. ConClusions: The L-NFL-III 
database can be a useful tool for epidemiological and outcomes research related to 
injuries in the NFL. In 4-year longitudinal analyses, this database was successful 
in identifying a large number of missed games due to injuries, as well other critical 
outcomes including season- and career-ending injuries.
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objeCtives: Health care databases represent an optimal tool for conducting large 
retrospective epidemiological studies and are largely used in Europe and the US. 
This study is the second phase of an earlier study which qualititatively describes 
databases in Asia Pacific. In this phase, we focused on several countries that have 
large health care databases used for administrative functions namely South 
analysis. The time horizon for each studies ranged from 2-3 months in the RCTs, 
and 1-24 months in the observational studies. No discounting was reported in any 
of the articles. Only one article reported sensitivity analysis. ConClusions: All HE 
studies published were piggy-backed to clinical studies and none utilised HE model-
ling.  None of the HE studies completely fulfilled the standard HE reporting criteria.
ReSeaRCh on MethodS – databases & Management Methods
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objeCtives: The main purpose of the present study was to assess the physicians 
need for the development of a supportive management database for the treatment 
of poisoning cases and to implement such a database in the hospital setup based on 
the need of the physicians. Methods: A prospective, observational study was con-
ducted in the emergency department of Kasturba Hospital, Manipal. The study was 
approved by the Institutional Ethics Committee of Kasturba Hospital, Manipal. A 12 
item questionnaire was developed, validated and given to 42 physicians who treated 
acute poisoning cases to assess their need for the development and implementation 
of a supportive management database. Material for the database was prepared after 
conducting an electronic literature search of various existing databases. Results: 
The 12 item questionnaire was given to seven experts for content validation. Out 
of twelve items, one item was excluded from the final questionnaire as it did not 
meet the required value. All 42 (100%) of the physicians believed that a supportive 
management database for poisoning cases in the hospital setup would be really 
helpful. Over 300 articles were referred in the preparation of the material for the 
database. ConClusions: Clinical pharmacists together with physicians who treat 
poisoning cases must work hand in hand in developing institutional guidelines for 
the management of poisoning. Development of such guidelines could reduce the 
complications and mortality which are associated with poisoning cases.
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objeCtives: Traditional large scale epidemiological surveys used to inform public 
health decision-making have limitations, notably the cost and time to administer 
them and the timeliness of the data, sometimes subject to 5 or more years between 
updates. This analysis aimed to validate a newer survey methodology by comparing 
output with that from two large scale health surveys. Methods: Data were drawn 
from the Adelphi Diabetes Disease Specific Programme (DSP), a cross-sectional sur-
vey of physicians and their patients conducted in China (2012) and United Kingdom 
(UK) (2013). Detailed records for 1662 patients were provided by 200 physicians 
in China. In the UK, 125 physicians provided records for 1237 patients.  Clinical 
and demographic characteristics of the samples were compared with independ-
ent representative national data sources:  a 2007/08 Chinese epidemiology study 
(46,239 patients) and the Health Survey for England 2011 (HSFE), administered to 
10,000 individuals. Variables common to both datasets were compared and tested 
for significant differences. Results: Systolic blood pressure (SBP) and low-density 
lipoprotein (LDL) values from the China DSP were statistically non-different from 
the national survey. There were differences between fasting plasma glucose (137.8 
vs. 158.6); age (56.6 vs. 55.8); male body mass index (BMI) (24.1 vs. 25.2) and high-
density lipoprotein. Comparing the UK DSP with the HSFE, all variables (age, gender, 
smoking status, age at diagnosis (61.5 vs. 63.9), insulin-treated, BMI (31.6 vs. 32.3), 
total cholesterol, HBA1C% (7.768 vs. 7.981), and SBP were non-different. Weeks since 
diagnosis differed - 358 DSP vs. 504 HSFE. ConClusions: Results demonstrate that 
the DSP methodology enables up-to-date representative sampling of treated adult 
patients in Western and Asian populations for national disease burden quantifica-
tion, and treatment pattern and outcomes assessment. A limitation is that sampled 
patients are more recently diagnosed, but there are otherwise only minor differ-
ences in clinical and demographic characteristics.
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objeCtives: The China public health insurance system now covers 95% of the 
population due to efforts to establish universal coverage under three primary gov-
ernment programs (Urban Employee Basic Medical Insurance, Urban Resident Basic 
Medical Insurance, and New Rural Cooperative Medical Scheme).  Data from these 
insurance programs are combined to create the China Health Insurance Association 
(CHIRA) database; the only national claims database in China.  Use of these data 
allow research to examine patients, settings, patterns and outcomes that may dif-
fer from that of RCTs; advancing China’s population-based research and enhanc-
ing the opportunity to apply real world evidence (RWE) in local decision making.  
The use of claims data is relatively uncommon in China. This work explores the 
current and potential use of local claims data as a source of information for RWE 
in China. Methods: The experience of the use of the China Health Insurance 
